Man using laptop
Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Xero Ltd (ASX:XRO) said its earnings before interest, tax, depreciation and amortisation (EBITDA) for the half of the 2025 fiscal year had jumped 51% (to $311.7 million) compared to the prior corresponding period.

The Wellinton-based company – which provides accounting software – also said earnings growth had been supported by a 25% rise in operating revenue (to $996 million), and an operating expense to revenue ratio of 71.2% for the period.

Xero’s free cash flow was also higher, rising to $208.7 million, alongside a free cash flow margin of 21.0% – improving from 13.3% in the prior period.

These figures meant the company maintained its greater than Rule of 40 outcome of 43.9%.

CEO Sukhinder Singh Cassidy said the results reflected Xero’s success in achieving strategic goals.

“We have delivered a solid performance across the board this half including continued strong revenue growth, and a greater than Rule of 40 outcome for the second period running,” he said.

“We’re executing our strategy with focus and purpose, through disciplined investment aligned to our strategic priorities.

“This has supported an improvement in product velocity for customers in line with
our Win the 3×3 strategic priority to build winning solutions for the three most critical small business jobs in our three largest markets.”

Xero has been trading at $161.55.

Join the discussion: See what HotCopper users are saying about Xero and be part of the conversations that move the markets.

XRO by the numbers
More From The Market Online
Market Update Graphic

ASX Market Update: Deepseek decimates AI-themed stocks | January 28, 2025

The tech sector has been heavily sold off as global markets respond to the rise of…
Ai image of a gold mine

Dreadnought scoping study aims for 20K oz in one year from Star of Mangaroon

Dreadnought Resources Ltd has published a scoping study for its Star of Mangaroon gold deposit in…
PET Scan machine

Telix clocks +150% year-on-year returns as radiopharma acquisition well received

Telix Pharmaceuticals (ASX:TLX) has joined a somewhat quiet cohort of ASX biotech companies having a pretty…
AI definitely did not mkae this

Fortescue is going to buy Red Hawk Mining. Why, and who are they?

Fortescue Metals (ASX:FMG) has indicated it's set to buyout ASX-listed Red Hawk Mining (ASX:RHK) for between…